Investors

Financials & Filings

Document Details

Form
Filing Date
Apr 24, 2025
Document Date
Dec 31, 2024
Form Description
An annual report to security holders
Filing Group
Annual Filings
Company
Xenon Pharmaceuticals Inc.
Issuer
Xenon Pharmaceuticals Inc.

Investor inquiries

Tucker Kelly 
Chief Financial Officer
investors@xenon-pharma.com
 

Email alerts

Sign up here to receive email alerts from Xenon Pharmaceuticals